Phase I, Open Label, Two Period Study to Evaluate the Effects of Fosamprenavir/Ritonavir on GSK1349572 Pharmacokinetics and a Phase I, Randomized, Three-Way Crossover Study to Evaluate the Relative Bioavailability of Three Tablet Variants Made Using Micronized, Unmicronized and Intermediate Particle Sizes of GSK1349572 in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2017
At a glance
- Drugs Dolutegravir (Primary) ; Fosamprenavir; Ritonavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 24 Jan 2011 Official Title amended as reported by ClinicalTrials.gov.
- 12 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Sep 2010 New trial record